Stay updated on INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial page.

Latest updates to the INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study page now displays a “Failed to fetch” error instead of a 403 Forbidden message, and the NIH transition notice is no longer displayed.SummaryDifference1%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH notice announces updates and FAQs during a transition, including the stated use of “Super Intelligence” in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error instead of loading the Researcher View details for NCT02172911, with the standard site chrome visible. This indicates an access restriction rather than an update to the study information.SummaryDifference19%

Stay in the know with updates to INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INO-3112 DNA Vaccine for Cervical Cancer Clinical Trial page.